Scholar Rock Holding (SRRK) Non-Current Debt (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Non-Current Debt came in at $196.6 million in Q1 2026, up 295.28% year-on-year from $49.7 million in Q1 2025, and up 97.19% quarter-over-quarter from $99.7 million in Q4 2025.

Scholar Rock Holding (SRRK) Non-Current Debt (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Non-Current Debt history runs 10 years deep, the most recent figure standing at $196.6 million for Q1 2026.

  • On a quarterly basis, Non-Current Debt rose 295.28% year-over-year to $196.6 million in Q1 2026; TTM through Mar 2026 was $196.6 million, a 295.28% increase from a year earlier, with the FY2025 full-year figure at $99.7 million, up 98.84% from the prior year.
  • Non-Current Debt grew to $196.6 million in Q1 2026 per SRRK's latest filing, from $99.7 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $196.6 million in Q1 2026 and bottomed at $38.8 million in Q2 2022.
  • The 5-year median for Non-Current Debt is $49.8 million (2022), against an average of $62.9 million.
  • Across the five-year window, Non-Current Debt declined 10.51% in 2024 and soared 295.28% in 2026, its largest moves.
  • Year by year, Non-Current Debt stood at $49.7 million in 2022, then slipped by 2.13% to $48.7 million in 2023, then gained by 3.0% to $50.1 million in 2024, then jumped by 98.84% to $99.7 million in 2025, then soared by 97.19% to $196.6 million in 2026.
  • Per Business Quant, the three latest SRRK Non-Current Debt figures stand at $196.6 million (Q1 2026), $99.7 million (Q4 2025), and $100.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 105.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 842.92 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.99 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - 196.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 196.61 Mn
Dec 31, 2025 99.71 Mn
Sep 30, 2025 100.00 Mn
Jun 30, 2025 49.76 Mn
Mar 31, 2025 49.74 Mn
Dec 31, 2024 50.15 Mn
Sep 30, 2024 50.10 Mn
Jun 30, 2024 48.49 Mn
Mar 31, 2024 44.59 Mn
Dec 31, 2023 48.68 Mn
Sep 30, 2023 49.96 Mn
Jun 30, 2023 49.90 Mn
Mar 31, 2023 49.83 Mn
Dec 31, 2022 49.74 Mn
Sep 30, 2022 49.77 Mn
Jun 30, 2022 38.81 Mn
Mar 31, 2022 43.62 Mn
Dec 31, 2021 48.42 Mn
Sep 30, 2021 24.93 Mn
Jun 30, 2021 24.85 Mn